Work

Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice

Year: 2026

Type: review

Source: The Lancet Infectious Diseases

DOI: 10.1016/s1473-3099(26)00351-8

Authors: Tom Boyles, Jayne Ellis, Nicholas Feasey, Scott K Heysell, Shevin T Jacob, Joseph Jarvis, Christopher C Moore, Edwin Nuwagira, Stellah G Mpagama

Institutions: University of the Witwatersrand, London School of Hygiene & Tropical Medicine, Infectious Diseases Institute, Makerere University, University of St Andrews, Liverpool School of Tropical Medicine, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, University of Virginia, Mbarara University of Science and Technology, Nelson Mandela African Institution of Science and Technology

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Allergy and Infectious Diseases

Awards: A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa, STeroids and enhanced Antibiotics for the treatment of patients in Africa with Refractory Sepsis: STARS trial

OpenAlex ID: W7171391976

FWCI:

Cites: 33

Cited by:

Related to: 10